What is Asmanex HFA?
Asmanex HFA is an inhaler that contains two medications: an inhaled corticosteroid (ICS) called mometasone furoate and a long-acting beta2-agonist (LABA) called formoterol fumarate [1]. It is used for the long-term control of asthma in patients 5 years of age and older [1]. The HFA in the name refers to hydrofluoroalkane, the propellant used in the inhaler [2].
How does Asmanex HFA work for asthma control?
Asmanex HFA works by reducing inflammation in the airways and relaxing the muscles around them [1]. Mometasone furoate, the corticosteroid component, works by decreasing inflammation in the lungs. Formoterol fumarate, the LABA component, relaxes the muscles in the airways, which helps to open them up and make breathing easier [1]. It is important to note that Asmanex HFA is a maintenance inhaler and should not be used to relieve sudden asthma symptoms [1].
When is Asmanex HFA prescribed?
Asmanex HFA is prescribed for patients who are already taking an inhaled corticosteroid and a long-acting beta2-agonist, or for patients whose asthma is not adequately controlled with an inhaled corticosteroid alone [1]. It is intended for regular, long-term use to prevent asthma symptoms, not to treat acute asthma attacks [1].
What are the potential side effects of Asmanex HFA?
Common side effects of Asmanex HFA can include headache, nasopharyngitis (cold-like symptoms), and oral candidiasis (thrush) [1]. Patients using Asmanex HFA should rinse their mouth with water after each use to help prevent thrush [1]. Other potential side effects include an increased risk of pneumonia, fractures, glaucoma, and cataracts [1].
When does the Asmanex HFA patent expire?
Information regarding specific patent expiry dates for Asmanex HFA can be found on resources like DrugPatentWatch.com [3]. Patent protection is crucial for pharmaceutical companies as it grants them market exclusivity for a defined period, allowing them to recoup research and development costs [3].
What are the alternatives to Asmanex HFA?
Other combination inhalers containing an ICS and a LABA are available for asthma management. Additionally, single-ingredient inhaled corticosteroids or other classes of asthma medications may be prescribed depending on the individual patient's needs and asthma severity [1]. The choice of treatment is determined by a healthcare professional based on a thorough assessment of the patient's condition.
Can children use Asmanex HFA?
Asmanex HFA is indicated for patients 5 years of age and older for the long-term control of asthma [1]. Its use in younger children is not recommended.
What is the difference between Asmanex HFA and Asmanex Twisthaler?
Asmanex HFA is a metered-dose inhaler that uses a hydrofluoroalkane propellant, while Asmanex Twisthaler is a dry powder inhaler [2]. Both deliver mometasone furoate, but the delivery mechanisms and propellant systems differ [2].
How is Asmanex HFA different from other ICS/LABA inhalers?
While Asmanex HFA contains mometasone furoate and formoterol fumarate, other ICS/LABA inhalers utilize different combinations of these drug classes. For example, some inhalers combine fluticasone propionate with salmeterol, or budesonide with formoterol. The specific combination and formulation can influence factors such as delivery efficacy and patient experience [1].
---
1. Asmanex HFA Prescribing Information.
2. DrugPatentWatch.com.
3. DrugPatentWatch.com.